Product Reports Resources Pricing Login Book a demo
COMPANY PROFILE

OctoPlus

Request full access

Develops pharmaceutical formulation solutions

Leiden, NetherlandsFounded 1995Biotech & Life Sciences

About OctoPlus

In 1995, from the biotech hub of Leiden in the Netherlands, two founders, Joost Holthuis and Daan Crommelin, started a company with a specific focus. That company was OctoPlus, a specialty pharmaceutical firm centered on the complex world of drug delivery. Their business was not about discovering new blockbuster drugs, but rather a more nuanced play: developing and manufacturing advanced, injectable formulations of new and existing medicines for other pharmaceutical companies. They built expertise in creating controlled-release and difficult-to-formulate products, helping partners move from the lab to the clinic. This strategy led them to a public listing on the Euronext Amsterdam exchange, a significant step for the Dutch company. The pivotal chapter in the OctoPlus story came in late 2012. Indian pharmaceutical giant Dr. Reddy's Laboratories announced it would acquire OctoPlus for around €27.4 million. For Dr. Reddy's, this wasn't just a purchase; it was a strategic move to acquire specialized technological capabilities and establish a research base in the heart of the European biotech scene. By 2013, the deal was complete, and OctoPlus was integrated, becoming a key research center for complex injectables for its new parent company.

Source: Dealroom company data

At a glance

Status
Acquired
Employees
78
Open positions
None listed
Dealroom signal
52.6/100
Industry
Health
Sub-industry
Pharmaceutical
Sector
Biotechnology, Horizon Europe
Business model
Manufacturing
Client focus
B2B

Funding history

3 recorded events

Company financing events and reported valuations.

Deal typeDateAmountValuationInvestorsSource
ACQUISITION✓Exit Oct 2012 $36M — Dr. Reddy’s Laboratories —
EARLY VCEquity / VC Feb 2011 $0 — Generis Capital Partners —
Showing the latest 2 of 3 recorded eventsBook a demo for the full funding history →

Growth signals

OctoPlus website traffic

Latest recorded traffic for OctoPlus is 0 monthly website visits. OctoPlus's team grew 7700% over the past year.

Latest monthly visits0 1-year team growth+7700%
Summary metrics are public; monthly history is available with a demoCompare with peers →

Similar companies

Closest operating peers by Dealroom taxonomy

Company identity and context are open; selected comparison metrics preview what is available on the platform.

Showing 8 of the closest matchesCompare every metric →

Investments and acquisitions

Capital deployed

Recent portfolio relationships for companies that also act as investors or acquirers.

OctoPlus in the Leiden ecosystem

Live from Dealroom

The OctoPlus office with the hot startups, most funded companies and investors around it. Hover or tap a pin.

Loading the map…

Dealroom maps whole ecosystems like this one for cities, regions and governments. See the ecosystem platform →

Investors

6 investors on the cap table

From Dealroom's funding and investor records, grouped by the round each investor first entered.

Series A4 investors entered at this stage

  • SR One
  • EQT Life Sciences
  • Innoven Partners
  • Generis Capital Partners

Other known investors2 additional known investors

  • Dr. Reddy’s Laboratories
  • Signet Healthcare Partners
Team profiled 12 named & role-tagged
Founders Hidden — book a demo/100 quality score
Key operators Hidden — book a demo quality score
Potential founders Hidden — book a demo likely future founders
Startup mafia Hidden — book a demo alumni-founded startups
Talent movements Hidden — book a demo in · Hidden — book a demo out past 12 months

Source: Dealroom Talent Intelligence.

Global footprint

Workforce and web traffic by country
Workforce by country
3 countries with
team presence
🇳🇱 Netherlands84.6%
🇮🇳 India7.7%
🇿🇦 South Africa7.7%
3 countries shown

Market sentiment

Posts on X, past 7 days

An AI-synthesised read of the highest-engagement posts about OctoPlus on X, ranked by likes and reposts, corporate channels excluded.

Reading the room on X — pulling top posts and synthesizing themes…

Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour

See OctoPlus’s full profile on Dealroom

Request a free trial to see the complete deal history, financials, people graph and growth signals.

Takes under a minute. Already use Dealroom? Log in.